To test whether anti-CTLA-4 VHH with or without half-life extender could show therapeutic effects in different syngeneic models, we evaluated anti-tumor effects of H11 and H11-HLE in MC38 and H22 tumor-bearing C57BL/6 mice and BALB/c mice, respectively. The gene discussed is CTLA4; the disease is neoplasm.